The Peptide Synthesis market size is USD 1.1 Billion in 2026.
The Peptide Synthesis market is projected to grow at a CAGR of 5% by 2033, reaching approximately USD 1.5 Billion.
The Peptide Synthesis market growth drivers include rising use in pharmaceutical drugs, increased R&D and research funding, and advancements in automated peptide synthesis technology.
North America is the dominating region for the Peptide Synthesis market.
AAPPTec, Biotage AB, Bachem Holding AG, CSBio Company Inc., and CEM Corporation are some leading industry players in the Peptide Synthesis market.